These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36270992)

  • 21. Population pharmacokinetic modeling of the influence of chronic and acute biofilm-forming Pseudomonas aeruginosa lung infection on ciprofloxacin free pulmonary and epithelial lining fluid concentrations.
    Lock GA; Helfer VE; Dias BB; Torres BGS; De Araújo BV; Dalla Costa T
    Eur J Pharm Sci; 2023 Oct; 189():106546. PubMed ID: 37517670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ciprofloxacin-eluting nanofibers inhibits biofilm formation by Pseudomonas aeruginosa and a methicillin-resistant Staphylococcus aureus.
    Ahire JJ; Neveling DP; Hattingh M; Dicks LM
    PLoS One; 2015; 10(4):e0123648. PubMed ID: 25853255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Ciprofloxacin and Its Copper Complex against Pseudomonas aeruginosa Biofilms.
    Tewes F; Bahamondez-Canas TF; Smyth HDC
    AAPS PharmSciTech; 2019 May; 20(5):205. PubMed ID: 31144198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pse-T2, an Antimicrobial Peptide with High-Level, Broad-Spectrum Antimicrobial Potency and Skin Biocompatibility against Multidrug-Resistant Pseudomonas aeruginosa Infection.
    Kang HK; Seo CH; Luchian T; Park Y
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30323036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pseudomonas aeruginosa corneal abscess refractory to fluoroquinolones].
    Díaz Valle D; Alós Cortés JI; Arteaga Sánchez A; Toledano Fernández N; Poza Morales Y; Díaz-Valle T
    Arch Soc Esp Oftalmol; 2002 Jul; 77(7):397-9. PubMed ID: 12098814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin treatment modulates the host immune system to enhance Pseudomonas aeruginosa wound biofilms.
    Watters C; Everett JA; Haley C; Clinton A; Rumbaugh KP
    Infect Immun; 2014 Jan; 82(1):92-100. PubMed ID: 24126517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should Pseudomonas aeruginosa isolates resistant to one of the fluorinated quinolones be tested for the others? Studies with an experimental model of pneumonia.
    Chidiac C; Roussel-Delvallez M; Guery B; Beaucaire G
    Antimicrob Agents Chemother; 1995 Mar; 39(3):677-9. PubMed ID: 7793872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart.
    Tran TT; Vidaillac C; Yu H; Yong VFL; Roizman D; Chandrasekaran R; Lim AYH; Low TB; Tan GL; Abisheganaden JA; Koh MS; Teo J; Chotirmall SH; Hadinoto K
    Int J Pharm; 2018 Aug; 547(1-2):368-376. PubMed ID: 29886096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
    Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
    AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual-responsive antibiotic and baicalein co-delivery nanoparticles with enhanced synergistic antibacterial activity.
    Liu Y; Qian J; Zhao X; Lan T; Luo Y; Guo Q; Shen X
    J Biomater Sci Polym Ed; 2023 Aug; 34(12):1741-1757. PubMed ID: 36799915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics.
    Orazi G; Ruoff KL; O'Toole GA
    mBio; 2019 Jul; 10(4):. PubMed ID: 31363032
    [No Abstract]   [Full Text] [Related]  

  • 32. Polyaspartate-derived synthetic antimicrobial polymer enhances the activity of rifampicin against multidrug-resistant
    Chaudhary N; Aggarwal B; Saini V; Srinivas Yavvari P; Sharma P; Srivastava A; Bajaj A
    Biomater Sci; 2022 Sep; 10(18):5158-5171. PubMed ID: 35833261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptomic determinants of the response of ST-111 Pseudomonas aeruginosa AG1 to ciprofloxacin identified by a top-down systems biology approach.
    Molina-Mora JA; Chinchilla-Montero D; Chavarría-Azofeifa M; Ulloa-Morales AJ; Campos-Sánchez R; Mora-Rodríguez R; Shi L; García F
    Sci Rep; 2020 Aug; 10(1):13717. PubMed ID: 32792590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium alginate-based antimicrobial film dressings for potential healing of infected foot ulcers.
    Ahmed A; Boateng J
    Ther Deliv; 2018 Feb; 9(3):185-204. PubMed ID: 29424287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudomonas aeruginosa biofilms perturb wound resolution and antibiotic tolerance in diabetic mice.
    Watters C; DeLeon K; Trivedi U; Griswold JA; Lyte M; Hampel KJ; Wargo MJ; Rumbaugh KP
    Med Microbiol Immunol; 2013 Apr; 202(2):131-41. PubMed ID: 23007678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
    Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
    Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced Clearing of Wound-Related Pathogenic Bacterial Biofilms Using Protease-Functionalized Antibiotic Nanocarriers.
    Weldrick PJ; Hardman MJ; Paunov VN
    ACS Appl Mater Interfaces; 2019 Nov; 11(47):43902-43919. PubMed ID: 31718141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial Peptides against Multidrug-Resistant
    Ben Hur D; Kapach G; Wani NA; Kiper E; Ashkenazi M; Smollan G; Keller N; Efrati O; Shai Y
    J Med Chem; 2022 Jul; 65(13):9050-9062. PubMed ID: 35759644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo selection of a target/efflux double mutant of Pseudomonas aeruginosa by ciprofloxacin therapy.
    Le Thomas I; Couetdic G; Clermont O; Brahimi N; Plésiat P; Bingen E
    J Antimicrob Chemother; 2001 Oct; 48(4):553-5. PubMed ID: 11581237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanophyto-gel against multi-drug resistant
    Wen MM; Abdelwahab IA; Aly RG; El-Zahaby SA
    Drug Deliv; 2021 Dec; 28(1):463-477. PubMed ID: 33620004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.